OpenAI acquires Orchestra Bio
modelsOpenAI NewsOct 20, 2026
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Impact: LowConfidence: MediumNovelty: Material
modelsopenai